Standard Biotools (LAB) Share-based Compensation Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.36% |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | 41.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.00% |
| Dec 31, 2025 | 42.04% |
| Sep 30, 2025 | 18.81% |
| Jun 30, 2025 | 4.83% |
| Mar 31, 2025 | 25.81% |
| Sep 30, 2024 | -26.56% |
| Jun 30, 2024 | -22.82% |
| Mar 31, 2024 | 46.71% |
| Dec 31, 2023 | -5.31% |
| Sep 30, 2023 | -8.07% |
| Jun 30, 2023 | -5.02% |
| Mar 31, 2023 | 9.99% |
| Dec 31, 2022 | -18.46% |
| Sep 30, 2022 | 14.05% |
| Jun 30, 2022 | 15.94% |
| Mar 31, 2022 | 21.19% |
| Sep 30, 2021 | 72.09% |
| Jun 30, 2021 | 54.61% |
| Mar 31, 2021 | 28.15% |
| Dec 31, 2020 | 27.07% |
| Sep 30, 2020 | 23.35% |
| Jun 30, 2020 | 15.99% |
| Mar 31, 2020 | -1.10% |
| Dec 31, 2019 | 3.16% |
| Sep 30, 2019 | -5.47% |
| Jun 30, 2019 | -7.09% |
| Mar 31, 2019 | -15.15% |
| Dec 31, 2018 | 7.93% |
| Sep 30, 2018 | -17.78% |
| Jun 30, 2018 | -24.36% |
| Mar 31, 2018 | -24.55% |
| Dec 31, 2017 | -52.22% |
| Mar 31, 2017 | -2.61% |
| Dec 31, 2016 | 17.15% |
| Sep 30, 2016 | -8.50% |
| Jun 30, 2016 | 29.94% |
| Dec 31, 2015 | 55.97% |
| Sep 30, 2015 | 60.62% |
| Jun 30, 2015 | 61.55% |
| Mar 31, 2015 | 65.34% |
| Dec 31, 2014 | 183.95% |
| Mar 31, 2014 | 49.66% |
| Dec 31, 2013 | 76.42% |
| Sep 30, 2013 | 123.37% |